Antiviral Agents

Antiviral agents are drugs that suppress the replication of viruses. Because viruses replicate using the machinery of the host cell, achieving selective toxicity is harder than for bacteria, and most antivirals target a specific viral enzyme or step in the viral life cycle, which makes them comparatively narrow in spectrum.

Definition

Antiviral agents are substances used to treat viral infections by inhibiting a step in viral replication—such as viral entry, the copying of the viral genome, the processing of viral proteins, or the release of new virus particles—usually by acting on a virus-specific molecular target.

Scope

This topic introduces what antiviral agents are, the stages of the viral life cycle they target, and why their development and use differ from antibacterial therapy. It is a conceptual reference and does not provide drug selection, dosing, or treatment regimens for any infection.

Core questions

• Why is selective toxicity harder to achieve against viruses than against bacteria?
• Which steps of the viral life cycle do antiviral agents target?
• Why are most antiviral agents active against only one or a few viruses?
• How does antiviral resistance arise and why does it constrain therapy?

Key concepts

• Selective toxicity against an intracellular pathogen
• Viral life cycle as a set of drug targets (entry, replication, protein processing, release)
• Nucleoside and nucleotide analogues
• Viral enzyme inhibitors (polymerase, protease, integrase)
• Narrow, virus-specific spectrum
• Antiviral resistance

Mechanisms

Antiviral agents act at defined points in the viral replication cycle. Some block viral entry or uncoating; nucleoside and nucleotide analogues are incorporated into the growing viral genome and terminate or corrupt its synthesis; other agents inhibit virus-encoded enzymes such as polymerases, proteases, or integrases that the virus needs to replicate. Because these targets are virus-specific, individual agents are typically active against only one or a few viruses, in contrast to the broader spectra seen with many antibacterials. Reliance on a single viral target also means that point mutations can confer resistance, which shapes how antiviral therapy is designed.

Clinical relevance

Antiviral agents underpin the management of important viral infections and are a distinct branch of anti-infective pharmacology that health-sciences readers should be able to distinguish from antibacterial therapy. This entry describes the class conceptually; it is not a source of drug choice, dosing, or regimens, which depend on the specific virus, the clinical situation, and current guidelines.

Evidence & guidelines

A comprehensive review of approved antiviral drugs over the past half-century traces how agents map onto particular viruses and replication steps; treatment recommendations for specific viral infections are set out in disease-specific clinical guidelines rather than in this reference.

History

Antiviral drug discovery accelerated from the second half of the twentieth century, beginning with nucleoside analogues and broadening over subsequent decades to enzyme inhibitors targeting a range of viruses; a 2016 review catalogues the agents approved across roughly fifty years of this effort.

Key figures

• Erik De Clercq

Seminal works

• declercq-li-2016

Frequently asked questions

Why do antibiotics not work against viruses?

Antibiotics act on structures and processes specific to bacteria, such as the bacterial cell wall or ribosome, which viruses do not have; viruses require antiviral agents that target steps in viral replication instead.

Why are antiviral agents usually specific to one virus?

Most antivirals act on a molecular target encoded by a particular virus, so an agent designed against one virus's enzyme generally has little activity against unrelated viruses with different targets.